HELE Quote, Financials, Valuation and Earnings

Kenvue, Inc. has a net margin of -71.19% compared to Helen of Troy Ltd.'s net margin of 10.58%. Helen of Troy Ltd.'s return on equity of -46.84% beat Kenvue, Inc.'s return on equity of 13.85%.

Helen of Troy Ltd. has a consensus price target of $29.33, signalling upside risk potential of 38.76%. On the other hand Kenvue, Inc. has an analysts' consensus of $19.33 which suggests that it could grow by 12.47%. Given that Helen of Troy Ltd. has higher upside potential than Kenvue, Inc., analysts believe Helen of Troy Ltd. is more attractive than Kenvue, Inc..

Helen of Troy Ltd. has a beta of 0.824, which suggesting that the stock is 17.627% less volatile than S&P 500. In comparison Kenvue, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Helen of Troy Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kenvue, Inc. offers a yield of 4.8% to investors and pays a quarterly dividend of $0.21 per share. Helen of Troy Ltd. pays -- of its earnings as a dividend. Kenvue, Inc. pays out 150.5% of its earnings as a dividend.

Helen of Troy Ltd. quarterly revenues are $433.6M, which are smaller than Kenvue, Inc. quarterly revenues of $3.8B. Helen of Troy Ltd.'s net income of -$308.6M is lower than Kenvue, Inc.'s net income of $398M. Notably, Helen of Troy Ltd.'s price-to-earnings ratio is 4.45x while Kenvue, Inc.'s PE ratio is 23.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen of Troy Ltd. is 0.27x versus 2.21x for Kenvue, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

The Beauty Health Co. has a net margin of -71.19% compared to Helen of Troy Ltd.'s net margin of -15.61%. Helen of Troy Ltd.'s return on equity of -46.84% beat The Beauty Health Co.'s return on equity of -19.76%.

Helen of Troy Ltd. has a consensus price target of $29.33, signalling upside risk potential of 38.76%. On the other hand The Beauty Health Co. has an analysts' consensus of $1.93 which suggests that it could grow by 32.42%. Given that Helen of Troy Ltd. has higher upside potential than The Beauty Health Co., analysts believe Helen of Troy Ltd. is more attractive than The Beauty Health Co..

Helen of Troy Ltd. has a beta of 0.824, which suggesting that the stock is 17.627% less volatile than S&P 500. In comparison The Beauty Health Co. has a beta of 1.181, suggesting its more volatile than the S&P 500 by 18.121%.

Helen of Troy Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Beauty Health Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen of Troy Ltd. pays -- of its earnings as a dividend. The Beauty Health Co. pays out -- of its earnings as a dividend.

Helen of Troy Ltd. quarterly revenues are $433.6M, which are larger than The Beauty Health Co. quarterly revenues of $70.7M. Helen of Troy Ltd.'s net income of -$308.6M is lower than The Beauty Health Co.'s net income of -$11M. Notably, Helen of Troy Ltd.'s price-to-earnings ratio is 4.45x while The Beauty Health Co.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen of Troy Ltd. is 0.27x versus 0.62x for The Beauty Health Co.. Usually stocks with elevated PS ratios are considered overvalued.

Solesence, Inc. has a net margin of -71.19% compared to Helen of Troy Ltd.'s net margin of -7.67%. Helen of Troy Ltd.'s return on equity of -46.84% beat Solesence, Inc.'s return on equity of 6.62%.

Helen of Troy Ltd. has a consensus price target of $29.33, signalling upside risk potential of 38.76%. On the other hand Solesence, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Helen of Troy Ltd. has higher upside potential than Solesence, Inc., analysts believe Helen of Troy Ltd. is more attractive than Solesence, Inc..

Helen of Troy Ltd. has a beta of 0.824, which suggesting that the stock is 17.627% less volatile than S&P 500. In comparison Solesence, Inc. has a beta of 1.066, suggesting its more volatile than the S&P 500 by 6.59%.

Helen of Troy Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solesence, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen of Troy Ltd. pays -- of its earnings as a dividend. Solesence, Inc. pays out -- of its earnings as a dividend.

Helen of Troy Ltd. quarterly revenues are $433.6M, which are larger than Solesence, Inc. quarterly revenues of $14.6M. Helen of Troy Ltd.'s net income of -$308.6M is lower than Solesence, Inc.'s net income of -$1.1M. Notably, Helen of Troy Ltd.'s price-to-earnings ratio is 4.45x while Solesence, Inc.'s PE ratio is 129.29x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen of Troy Ltd. is 0.27x versus 2.08x for Solesence, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Waldencast Plc has a net margin of -71.19% compared to Helen of Troy Ltd.'s net margin of --. Helen of Troy Ltd.'s return on equity of -46.84% beat Waldencast Plc's return on equity of -5.64%.

Helen of Troy Ltd. has a consensus price target of $29.33, signalling upside risk potential of 38.76%. On the other hand Waldencast Plc has an analysts' consensus of $3.20 which suggests that it could grow by 60.8%. Given that Waldencast Plc has higher upside potential than Helen of Troy Ltd., analysts believe Waldencast Plc is more attractive than Helen of Troy Ltd..

Helen of Troy Ltd. has a beta of 0.824, which suggesting that the stock is 17.627% less volatile than S&P 500. In comparison Waldencast Plc has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Helen of Troy Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Waldencast Plc offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Helen of Troy Ltd. pays -- of its earnings as a dividend. Waldencast Plc pays out -- of its earnings as a dividend.

Helen of Troy Ltd. quarterly revenues are $433.6M, which are larger than Waldencast Plc quarterly revenues of --. Helen of Troy Ltd.'s net income of -$308.6M is higher than Waldencast Plc's net income of --. Notably, Helen of Troy Ltd.'s price-to-earnings ratio is 4.45x while Waldencast Plc's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Helen of Troy Ltd. is 0.27x versus 0.81x for Waldencast Plc. Usually stocks with elevated PS ratios are considered overvalued.